These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4287073)

  • 1. Immunochemical study of parainfluenza virus (type 2) in amnion cells.
    De Vaux St Cyr C; Howe C
    J Bacteriol; 1966 May; 91(5):1911-6. PubMed ID: 4287073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal neuraminidase.
    Lee LT; Howe C
    J Bacteriol; 1966 Apr; 91(4):1418-26. PubMed ID: 4379674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple harvest technic for production of parainfluenza and measles hemagglutinating antigens.
    Palmer DF; Bucca MA
    Health Lab Sci; 1967 Apr; 4(2):126-8. PubMed ID: 4290560
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth studies of parainfluenza virus (type 2).
    Howe C; Milliken SA; Newcomb EW
    Arch Gesamte Virusforsch; 1970; 29(1):50-62. PubMed ID: 4318110
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses.
    Ray R; Compans RW
    Virology; 1986 Jan; 148(1):232-6. PubMed ID: 2417412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity against parainfluenza-3 virus in cattle: anti-neuraminidase activity in serum and nasal secretion.
    Morein B; Höglund S; Bergman R
    Infect Immun; 1973 Oct; 8(4):650-6. PubMed ID: 4355138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated fusion of FL amnion cells infected with parainfluenza virus type 2.
    Wainberg MA; Howe C
    Immunol Commun; 1972; 1(5):481-9. PubMed ID: 4375667
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative studies on susceptibility of established cell lines to parainfluenza 3 virus.
    Luczak M; Korbecki M
    Acta Virol; 1970 Jul; 14(4):279-84. PubMed ID: 4096951
    [No Abstract]   [Full Text] [Related]  

  • 9. Contribution to the study of the parainfluenza antigens.
    Bosshard S; Aymard M; Kessler N
    Dev Biol Stand; 1975; 28():18-27. PubMed ID: 165116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parainfluenza virus type 2 haemagglutinin-neuraminidase glycoprotein characterized with monoclonal antibodies.
    Rydbeck R; Löve A; Orvell C
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():931-5. PubMed ID: 2451708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.
    van Wyke Coelingh KL; Winter CC; Jorgensen ED; Murphy BR
    J Virol; 1987 May; 61(5):1473-7. PubMed ID: 2437318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A note on the interpretation of identity reactions in immunoelectrophoresis.
    Danielsen M; Sjöström H; Norén O
    Scand J Immunol; 1977; 6(12):1323-7. PubMed ID: 415353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological diagnosis of parainfluenza virus infections by enzyme immunoassay with special emphasis on purity of viral antigens.
    Julkunen I
    J Med Virol; 1984; 14(2):177-87. PubMed ID: 6092530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.
    van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR
    J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children.
    Kasel JA; Frank AL; Keitel WA; Taber LH; Glezen WP
    J Virol; 1984 Dec; 52(3):828-32. PubMed ID: 6092715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies.
    Tsurudome M; Nishio M; Komada H; Bando H; Ito Y
    Virology; 1989 Jul; 171(1):38-48. PubMed ID: 2545038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of poly I:C on parainfluenza 3 virus multiplication in WISH cells.
    Korbecki M; Luczak M; Kobus M
    Acta Virol; 1971 Mar; 15(2):175. PubMed ID: 4396418
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection.
    Spriggs MK; Collins PL; Tierney E; London WT; Murphy BR
    J Virol; 1988 Apr; 62(4):1293-6. PubMed ID: 2831389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of host antigens with a parainfluenza virus.
    Isacson P; Koch AE
    Virology; 1965 Oct; 27(2):129-38. PubMed ID: 4284653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.